Home 2019
Archives
CV Risk Lower With Metformin in T2DM + Reduced Kidney Function
Risk for major adverse cardiovascular events reduced with metformin compared with a sulfonylurea
Lower Systolic BP Goal May Cut Risk for Orthostatic Hypotension
Lower systolic BP goal did not affect dizziness or lightheadedness in adults with recent stroke
Greater Cognitive Decline Seen in Seniors Unaware of Having HTN
Those on antihypertensive treatment have smaller cognition decline, similar to those without HTN
Decline in Heart Failure Mortality Rates Offset by Comorbidities
Treatments focused only on cardiovascular outcomes insufficient for improving heart failure patient survival
ESC Guidelines Updated for Managing CVD in Diabetes
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA tx
Metabolic Surgery May Reduce CV Risk in T2DM With Obesity
Reduction seen in primary end point and seven prespecified secondary outcomes, including mortality
Leading Causes of Adult Mortality Vary by Country Income Levels
Modifiable risk factors account for about 70 percent of cardiovascular disease cases, deaths
Sacubitril-Valsartan Does Not Impact Aortic Stiffness in HFrEF
But it is linked to improvements in cardiac structure, function including decreases in LVESVI, LVEDVI
ESC Guidelines Updated for Diagnosis, Treatment of PE
Dedicated algorithms proposed for management of high-risk PE, diagnosis of suspected PE in pregnancy
ESC Guidelines Updated for Supraventricular Tachycardia
Catheter ablation recommended, should be considered for many patients with SVT
